Supernus, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 6,561,205 |
| Open | 26.81 |
| Bid (Size) | 27.98 (100) |
| Ask (Size) | 29.00 (100) |
| Prev. Close | 28.15 |
| Today's Range | 26.74 - 28.99 |
| 52wk Range | 27.97 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
US Top Movers: Small-Cap Gainers and Losers in Today's Session ↗
November 03, 2026
Via Chartmill
US Top Movers: Gainers and Losers for Nov. 3, 2026 ↗
November 03, 2026
Via Chartmill
Performance
52-Week Range
52.7% below 52-week high
28.21
27.9752W Low
59.6852W High
1 Week
36.3% below 1-week high
27.971W Low
44.311W High
Supernus, Inc. - Common Stock (SUPN) traded between $27.97 and $59.68 over the past 52 weeks and last traded at $28.21, 52.7% below its 52-week high. Over the past week it ranged between $27.97 and $44.31.
Past 12 Months
-31.3%
-34.0%
-34.8%
-42.7%
-43.0%
-49.4%
1W
-$12.87
1M
-$14.55
3M
-$15.04
6M
-$20.98
YTD
-$21.26
1Y
-$27.49
SUPN was -49.4% over the past year, -42.7% over six months, -43.0% year to date, -31.3% in the last week.
12 Months vs Market
SUPN
-49.4%
DIA
+12.6%
SPY
+12.2%
QQQ
+9.5%
IWM
+15.7%
Over the past 12 months SUPN returned -49.4% versus DIA (Dow) +12.6%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +9.5% and IWM (Russell 2000) +15.7%.
Volume & Liquidity
7.06× 3-mo avg
Today 6,561,205
3-mo avg 929.2K
1W
2.7M
1M
1.3M
3M
929.2K
6M
873.3K
YTD
801.7K
1Y
808.3K
SUPN most recently traded 6,561,205 shares against a 3-month average daily volume of 929.2K.
More News
Read More
US Stock Gap Movers: Up and Down Names in Today's Session ↗
November 03, 2026
Via Chartmill
Via Chartmill
Supernus (SUPN) Q3 2026 Earnings Call Transcript ↗
October 30, 2026
Via The Motley Fool
Topics
Earnings
Supernus Pharmaceuticals Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics
Earnings
Supernus Announces Third Quarter 2026 Financial Results
October 29, 2026
Via GlobeNewswire
Supernus Pharmaceuticals earnings: what to look for from SUPN
October 27, 2026
Via StockStory
Topics
Artificial Intelligence
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore
October 14, 2026
Via StockStory
Topics
Supply Chain
1 Healthcare Stock Worth Your Attention and 2 We Turn Down
October 09, 2026
Via StockStory
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
Via StockStory
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
Via StockStory
Topics
Credit Cards
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
Via StockStory
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Via StockStory
1 of Wall Street’s Favorite Stocks with Promising Prospects and 2 Facing Headwinds
September 08, 2026
Via StockStory
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
Via GlobeNewswire
Frequently Asked Questions
Is Supernus, Inc. - Common Stock publicly traded?
Yes, Supernus, Inc. - Common Stock is publicly traded.
What exchange does Supernus, Inc. - Common Stock trade on?
Supernus, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus, Inc. - Common Stock?
The ticker symbol for Supernus, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus, Inc. - Common Stock?
The current price of Supernus, Inc. - Common Stock is 28.21
When was Supernus, Inc. - Common Stock last traded?
The last trade of Supernus, Inc. - Common Stock was at 11/04/26 04:00 PM ET
What is the market capitalization of Supernus, Inc. - Common Stock?
The market capitalization of Supernus, Inc. - Common Stock is 1.50B
How many shares of Supernus, Inc. - Common Stock are outstanding?
Supernus, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>